empagliflozin/ezetimibe/rosuvastatin (HODO-2225) / Hyundai Pharm - LARVOL DELTA

PREMATURE CORONARY ARTERY DISEASE IN A YOUNG WOMAN WITH MULTIPLE CARDIOMETABOLIC RISK FACTORS AND ELEVATED LIPOPROTEIN(A): THE IMPORTANCE OF EARLY PREVENTIVE MEASURES - Sara G. Zollota (ACC 2025) - "Postoperatively, she was started on aspirin, clopidogrel, rosuvastatin, ezetimibe and empagliflozin...Tirzepatide was initiated, home sleep study was ordered, and she was referred to cardiac rehabilitation.Decision-making: This case underscores the importance of recognizing premature CAD in young patients, especially women... This case highlights the importance of comprehensive risk modification, Lp(a) screening, aggressive primary prevention and the potential role for cardiometabolic clinics, particularly in patients with high ASCVD risk and family history."

Clinical • Acute Coronary Syndrome • Atherosclerosis • Cardiovascular • CNS Disorders • Coronary Artery Disease • Depression • Diabetes • Dyslipidemia • Genetic Disorders • Hypertension • Metabolic Disorders • Obesity • Pain • Polycystic Ovary Syndrome • Psychiatry • Type 2 Diabetes Mellitus